PRESS RELEASE published on 06/10/2024 at 23:22, 2 years 5 months ago GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary Cholangitis GENFIT achieves historic milestone with U.S. FDA accelerated approval of Ipsen's Iqirvo® for Primary Biliary Cholangitis. Elafibranor tablets approved as first-in-class treatment, marking a significant development in rare liver disease treatment landscape Primary Biliary Cholangitis GENFIT Ipsen Iqirvo FDA Accelerated Approval
BRIEF published on 05/29/2024 at 22:15, 2 years 5 months ago GENFIT to Present Latest ACLF Research at EASL Congress™ 2024 Research Collaboration GENFIT ACLF EASL Congress Liver Disease
PRESS RELEASE published on 05/29/2024 at 22:10, 2 years 5 months ago GENFIT to Present Latest ACLF Research at EASL Congress™ 2024 GENFIT to present latest ACLF research at EASL Congress™ 2024, showcasing collaborative efforts with EF CLIF to advance understanding of ACLF pathophysiology and treatment approaches Liver Diseases GENFIT ACLF Research EASL Congress 2024 EF CLIF Partnership
BRIEF published on 05/14/2024 at 22:15, 2 years 5 months ago GENFIT Announces Q1 2024 Financials and Projects Cash Runway into Late 2025 Cash Position Clinical Trials Revenue Decline Biopharmaceutical Industry GENFIT Financial Results
PRESS RELEASE published on 05/14/2024 at 22:10, 2 years 5 months ago GENFIT Reports First Quarter 2024 Financial Information GENFIT reports Q1 2024 financial information showing cash position of €74.0 million and revenues of €1.1 million. Company expects cash to fund operations until Q4 2025 Financial Information Revenues Cash Position Q1 2024 GENFIT
Published on 11/10/2026 at 23:30, 1 hour 18 minutes ago CCL Industries Announces 2026 Third Quarter Results
Published on 11/10/2026 at 23:00, 1 hour 48 minutes ago Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/10/2026 at 23:00, 1 hour 48 minutes ago Battery X Metals Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/10/2026 at 23:00, 1 hour 48 minutes ago Condor Agrees to Short Extension of Lucero Closing Payment with ELEMENT79 and Provides Huiñac Punta Drill Program Update
Published on 11/10/2026 at 22:30, 2 hours 18 minutes ago Amdocs Announces First Quarter Fiscal 2027 Investor Conference Schedule
Published on 11/11/2026 at 00:15, 32 minutes ago Lean Focus Launches Asia Pacific: Local Expertise. Global Impact.
Published on 11/10/2026 at 23:15, 1 hour 32 minutes ago GSMA MWC26 Doha welcomed over 10,000 attendees, as world-first ITU co-location puts MENA at the centre of global connectivity policy and innovation
Published on 11/10/2026 at 18:54, 5 hours 53 minutes ago REPLOID Group AG pursues entry in the US market and secures exclusivity to conduct due diligence for the potential acquisition of Chapul, LLC.
Published on 11/10/2026 at 17:31, 7 hours 16 minutes ago CNP Assurances SA announces the success of the issuance of a €500 million Tier 2 subordinated bond.
Published on 11/10/2026 at 14:00, 10 hours 47 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026
Published on 11/10/2026 at 11:02, 13 hours 45 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 17 hours 48 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/09/2026 at 18:30, 1 day 6 hours ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
